Titan Bio-Tech share news, announcements and annual reports
BSE: 524717Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹360.45.
30 Oct: open ₹364.90, high ₹364.95, low ₹335.40
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,755 Cr1,287th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 51.81
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.67
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.12%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.02
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 49,199
Titan Bio-Tech share news and announcements
605 announcements, routine notices left out, newest first. Page 8 of 13.
Aug 2019
Jul 2019
20 Jul · Shareholding for the Period Ended June 30, 2019
Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click ....15 Jul · Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 08 Jul · Board meeting
Meeting on 18 Jul 2019: quarterly results
Jun 2019
May 2019
29 May · Announcement under Regulation 30 (LODR)-Meeting Updates
29 May · Announcement under Regulation 30 (LODR)-Meeting Updates
29 May · Announcement under Regulation 30 (LODR)-Meeting Updates
14 May · Board meeting
Meeting on 29 May 2019: audited results
Apr 2019
19 Apr · Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 3 2 119 Apr · Shareholding for the Period Ended March 31, 2019
Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click ....
Mar 2019
20 Mar · Management
13 Mar · Management
Feb 2019
11 Feb · Results
Jan 2019
22 Jan · Board meeting
Meeting on 11 Feb 2019: quarterly results19 Jan · Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 015 Jan · Shareholding for the Period Ended December 31, 2018
Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click ....
Nov 2018
13 Nov · Announcement Under Regulation 30 : Reconstitution Of Nomination And Remuneration Committee
Oct 2018
29 Oct · Announcement under Regulation 30 (LODR)-Allotment
29 Oct · Board meeting